Price $330.10 |
Market Cap
14.42B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
71.8
|
P/B
11.3
|
P/S
17.53
|
Dividend %
-
|
|
P/CF
226.9
|
P/FCF
60.7
|
Op. Cash Flow
274.7K
|
FCF
5.1
|
|
Op. Margin
27.10%
|
Net Margin
24.70%
|
ROE
17.40%
|
ROI
17.90%
|
|
ROA
15.40%
|
EPS Growth
-18.10%
|
Current Ratio
4.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| NuVasive, Inc. (NUVA) | $68.88 | - | - | 3.37B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.11 | - | - | 12.5B | Strong Buy |
| Medicure Inc (MCUJF) | $1.30 | - | - | 12.6M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $66.08 | - | 3.10% | 141.03B | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.97 | - | - | 45.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
